Draft Recommendation Statement and Draft Evidence Reviews: Screening for Lead - US Preventive Services Task Force

Opportunity for Public Comment - US Preventive Services Task Force

Draft Recommendation Statement and Draft Evidence Reviews: Screening for Lead

Public Comment on Draft Recommendation Statement and Draft Evidence Reviews: Screening for Elevated Lead Levels in Children and Pregnant Women The U.S. Preventive Services Task Force seeks comments on a draft recommendation statement and draft evidence reviews on screening for elevated lead levels in children and pregnant women. The Task Force’s draft recommendation calls for more research on how clinicians can help prevent health problems related to lead exposure in children and pregnant women. The draft recommendation statement and draft evidence reviews are available for review and public comment from October 30, 2018 to December 3, 2018 here. The Draft Recommendation Statement and Draft Evidence Reviews Are Open to Public Comment

COMMENTING DETAILS

Public Comment Period: 10/30/18 - 12/3/18 Any visitor to the Task Force Web site can comment on any of the listed USPSTF draft documents. However, readers should note that the USPSTF writes these documents for researchers, primary care doctors, and other health care providers, using medical and scientific language as appropriate for these audiences.

DRAFT RECOMMENDATION SUMMARY

Population Recommendation Grade Children The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for elevated blood lead levels in asymptomatic children. I Pregnant woman The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for elevated blood lead levels in asymptomatic pregnant women. I

See the full draft recommendation statement

WHERE WE ARE IN THE PROCESS

Draft Research Plan Final Research Plan Draft Recommendation / Draft Evidence Review Final Recommendation / Evidence Summary